Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Atai Life Sciences N : Jefferies Starts Atai Life Sciences at Buy with $27 Price Target

09/01/2021 | 09:54am EST


ę MT Newswires 2021
All news about ATAI LIFE SCIENCES N.V.
11/30Maxim Group Initiates Coverage on Atai Life Sciences With Buy Rating, $25 Price Target
MT
11/29Atai Life Sciences Boosts Stake in Compass Pathways
MT
11/29Atai Life Sciences Increases its Ownership Position in COMPASS Pathways
AQ
11/22HC Wainwright Adjusts Atai Life Sciences to $50 From $40, Reiterates Buy Rating
MT
11/17Berenberg Bank Adjusts Atai Life Sciences' Price Target to $38 From $35, Maintains Buy ..
MT
11/16RBC Trims Price Target on Atai Life Sciences to $17 From $19, Maintains Sector Perform ..
MT
11/15ATAI LIFE SCIENCES N.V. Management's Discussion and Analysis of Financial Condition an..
AQ
11/15European ADRs Move Slightly Higher in Monday Trading
MT
11/15ATAI Life Sciences' Q3 Loss Narrows
MT
11/15ATAI LIFE SCIENCES N : Reports Third Quarter 2021 Financial Results and Corporate Update -..
PU
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
More recommendations
Financials (USD)
Sales 2021 18,5 M - -
Net income 2021 -118 M - -
Net cash 2021 407 M - -
P/E ratio 2021 -12,8x
Yield 2021 -
Capitalization 1 696 M 1 696 M -
EV / Sales 2021 69,5x
EV / Sales 2022 22 411x
Nbr of Employees 35
Free-Float 90,8%
Chart ATAI LIFE SCIENCES N.V.
Duration : Period :
Atai Life Sciences N.V. Technical Analysis Chart | ATAI | NL0015000DX5 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 10,58 $
Average target price 29,92 $
Spread / Average Target 183%
EPS Revisions
Managers and Directors
Florian Brand Chief Executive Officer
Gregory L. Weaver Chief Financial Officer
Srinivas G. Rao Chief Scientific Officer
Rolando GutÝerrez-Esteinou Chief Medical Officer
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ATAI LIFE SCIENCES N.V.0.00%1 696
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-42.48%24 298